Bafna Pharmaceuticals Ltd

NSE: BAFNAPH · BSE: 532989 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹401.85
Market cap: ₹950.6 Cr
Revenue (annual): ₹150.6 Cr
Net profit (annual): ₹11.10 Cr
P/E (TTM): 122.1×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Board Meeting Date 2 Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

15 Apr 2026 10:48 IST BSE

Price Movement Clarification

Bafna Pharmaceuticals Price Movement Clarification

Bafna Pharmaceuticals Ltd clarified to stock exchanges that recent significant share price movements are market-driven and attributable to general market conditions. The company confirmed it has not withheld any price-sensitive information and remains compliant with all SEBI disclosure regulations. Management stated they have no connection with or control over the share price movement.

Read the filing ↗